FI840734A - BENZAMIDDERIVAT. - Google Patents

BENZAMIDDERIVAT. Download PDF

Info

Publication number
FI840734A
FI840734A FI840734A FI840734A FI840734A FI 840734 A FI840734 A FI 840734A FI 840734 A FI840734 A FI 840734A FI 840734 A FI840734 A FI 840734A FI 840734 A FI840734 A FI 840734A
Authority
FI
Finland
Prior art keywords
benzamidderivat
Prior art date
Application number
FI840734A
Other languages
Finnish (fi)
Other versions
FI79297C (en
FI840734A0 (en
FI79297B (en
Inventor
Mose Da Prada
Renato Joos
Emilio Kyburz
Pierre Charles Wyss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI840734A0 publication Critical patent/FI840734A0/en
Publication of FI840734A publication Critical patent/FI840734A/en
Application granted granted Critical
Publication of FI79297B publication Critical patent/FI79297B/en
Publication of FI79297C publication Critical patent/FI79297C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI840734A 1983-03-03 1984-02-22 Process for the preparation of pharmacologically active benzamide derivatives FI79297C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH115083 1983-03-03
CH1150/83A CH653670A5 (en) 1983-03-03 1983-03-03 BENZAMIDE DERIVATIVES.

Publications (4)

Publication Number Publication Date
FI840734A0 FI840734A0 (en) 1984-02-22
FI840734A true FI840734A (en) 1984-09-04
FI79297B FI79297B (en) 1989-08-31
FI79297C FI79297C (en) 1989-12-11

Family

ID=4203649

Family Applications (1)

Application Number Title Priority Date Filing Date
FI840734A FI79297C (en) 1983-03-03 1984-02-22 Process for the preparation of pharmacologically active benzamide derivatives

Country Status (28)

Country Link
JP (1) JPS59167552A (en)
KR (1) KR910008202B1 (en)
AR (1) AR243155A1 (en)
AT (1) AT390948B (en)
AU (2) AU570431B2 (en)
BE (1) BE899059A (en)
CA (1) CA1252794A (en)
CH (1) CH653670A5 (en)
DE (1) DE3407654C2 (en)
DK (1) DK166382C (en)
ES (3) ES530230A0 (en)
FI (1) FI79297C (en)
FR (1) FR2541996B1 (en)
GB (1) GB2135998B (en)
GR (1) GR81866B (en)
HU (1) HU193556B (en)
IE (1) IE57004B1 (en)
IL (1) IL71078A (en)
IT (1) IT1173365B (en)
LU (1) LU85231A1 (en)
MC (1) MC1568A1 (en)
NL (1) NL8400459A (en)
NO (1) NO165999C (en)
NZ (1) NZ207272A (en)
PH (1) PH19623A (en)
PT (1) PT78187B (en)
SE (1) SE466447B (en)
ZA (1) ZA841394B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261335A (en) * 1984-08-29 1989-09-26 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Ethylenediamine monoamide derivatives
US4772630A (en) * 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
FR2642972B1 (en) * 1989-02-14 1994-08-05 Inst Nat Sante Rech Med AGENTS FOR THE DIAGNOSIS AND TREATMENT OF MELANOMAS, HALOGENATED AROMATIC DERIVATIVES SUITABLE FOR USE AS SUCH AGENTS AND THEIR PREPARATION
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342679A (en) * 1967-09-19 Parts by weight of acid chloride to react with parts of amine in
FR6557M (en) * 1967-06-20 1968-12-23 Ile De France
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions
GB1520584A (en) * 1975-04-02 1978-08-09 Yamanouchi Pharma Co Ltd 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions
DE2616486A1 (en) * 1976-04-14 1977-11-03 Basf Ag Perylene tetracarboxylic acid diimide pigments - for use in paints, thermoplastics, etc. and as vat dyes
CA1206964A (en) * 1980-11-12 1986-07-02 Nobuo Shinma Tetra-substituted benzene derivatives
DE3200258A1 (en) * 1982-01-07 1983-07-21 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München SUBSTITUTED 1-BENZOYL-2-PHENYLIMINO IMIDAZOLIDINE, THE ACID ADDITION SALTS THEREOF, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THE SAME
IL69997A0 (en) * 1983-01-03 1984-01-31 Miles Lab Procainamide and n-acetylprocainamide immunogens,antibodies prepared therefrom,labeled conjugates,and the use of such antibodies and labeled conjugates in immunoassays
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides

Also Published As

Publication number Publication date
NZ207272A (en) 1987-07-31
AT390948B (en) 1990-07-25
DK147584D0 (en) 1984-02-29
FI79297C (en) 1989-12-11
FR2541996B1 (en) 1987-12-11
CA1252794A (en) 1989-04-18
FI840734A0 (en) 1984-02-22
JPH0430389B2 (en) 1992-05-21
PT78187A (en) 1984-04-01
PT78187B (en) 1986-08-05
KR840009077A (en) 1984-12-24
NO165999B (en) 1991-02-04
LU85231A1 (en) 1985-09-12
ES8504680A1 (en) 1985-05-01
IL71078A (en) 1987-12-31
NO165999C (en) 1991-05-15
SE8401190D0 (en) 1984-03-02
GB8405486D0 (en) 1984-04-04
CH653670A5 (en) 1986-01-15
FR2541996A1 (en) 1984-09-07
IE57004B1 (en) 1992-03-11
ES8506601A1 (en) 1985-08-16
AU2506684A (en) 1984-09-06
GR81866B (en) 1984-12-12
KR910008202B1 (en) 1991-10-11
DK166382B (en) 1993-05-10
NO840797L (en) 1984-09-04
PH19623A (en) 1986-06-04
BE899059A (en) 1984-09-03
GB2135998A (en) 1984-09-12
IE840512L (en) 1984-09-03
MC1568A1 (en) 1985-02-04
IL71078A0 (en) 1984-05-31
HU193556B (en) 1987-10-28
IT1173365B (en) 1987-06-24
FI79297B (en) 1989-08-31
ZA841394B (en) 1985-06-26
DE3407654C2 (en) 1994-04-07
IT8419778A0 (en) 1984-02-23
DK147584A (en) 1984-09-04
ES530230A0 (en) 1985-05-01
SE8401190L (en) 1984-09-04
AU609758B2 (en) 1991-05-09
NL8400459A (en) 1984-10-01
ES537045A0 (en) 1985-08-16
ES537046A0 (en) 1985-08-16
AU570431B2 (en) 1988-03-17
AR243155A1 (en) 1993-07-30
SE466447B (en) 1992-02-17
ATA72484A (en) 1990-01-15
DK166382C (en) 1993-09-27
ES8506600A1 (en) 1985-08-16
DE3407654A1 (en) 1984-09-06
JPS59167552A (en) 1984-09-21
AU8307987A (en) 1988-06-16
GB2135998B (en) 1986-09-24

Similar Documents

Publication Publication Date Title
DE3484505D1 (en) IMMUNTEST.
ATE99311T1 (en) CARBOXYALKENAMIDOCEPHALOSPORINS.
FI73494B (en) STOEDSKO.
FI830256L (en) SILPLAOT.
FI81916B (en) FOER STRAOLNING KAENSLIG SKIVA.
DE3483306D1 (en) MICROCALCULATOR.
FI830012L (en) ROERBANDTRANSPORTOER.
DE3484698D1 (en) ANTI-MEDIUM.
DE3482323D1 (en) BENZOPYRANISOMERS.
DE3480652D1 (en) BENZOCYCLOAL CANDERIVIVES.
DE3485948D1 (en) HEPATITIS-A-UNIT-ANTIGEN.
FI830043L (en) MJUKVAEVNADSFILTERANORDNING.
FI830016L (en) HAOLSKIVA FOER EN INLOPPSLAODA FOER EN PAPPERSMASKIN.
FI73488B (en) SYLLKONSTRUKTION.
DE3484095D1 (en) TRANSFORMER-FREE COUNTER-STAGE.
DE3483137D1 (en) EC-TORFELD.
FI830202L (en) Hugg.
FI840734A (en) BENZAMIDDERIVAT.
FI73512B (en) ELEKTRISK AONGGENERATOR.
FI78617B (en) ROENTGENKONTRASTMEDEL.
DE3485726D1 (en) MICROPOZESSOR.
FI830108L (en) DUBBNINGSMASKIN.
ATE33444T1 (en) AXOPROSTHETATION.
ES271443Y (en) PLUG-SEAL.
ES272051Y (en) BROKEN-SUBSOLADOR.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE AG